Ultra Market Research | Global Inhalation Anesthesia Market
Global Inhalation Anesthesia Market
Report ID : 905
Category : Pharmaceuticals,Global
No Of Pages : 137
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Inhalation Anesthesia Market
Introduction Global Inhalation Anesthesia Market is a critical component of modern surgical procedures, focusing on delivering anesthetic agents through inhalation to induce and maintain anesthesia during surgeries. The agents include volatile anesthetics such as sevoflurane, isoflurane, and desflurane, which are favored due to their rapid onset and recovery properties. The market is seeing an enhanced growth rate due to an augmented number of surgeries worldwide, advancements in healthcare infrastructure, and the increasing prevalence of chronic diseases. Emerging trends are concerned with the development of more eco-friendly anesthetic agents to reduce the impact upon the environment. By the year 2024, it is estimated to be valued at USD 1.43 billion and expected to grow at a CAGR of 4.9% through 2030, driven by an ever-increasing surgical volume and innovations in anesthetic technologies.
Segmentation By Product Type • Volatile Anesthetics o Sevoflurane o Isoflurane o Desflurane o Others • Gaseous Anesthetics o Nitrous Oxide o Others
By Application • General Surgeries o Cardiovascular Surgeries o Neurosurgeries o Orthopedic Surgeries • Specialized Surgeries o Pediatric Surgeries o Obstetrics and Gynecology o Others
By End-User • Hospitals o Public Hospitals o Private Hospitals • Ambulatory Surgical Centers • Specialty Clinics
By Geography • North America o United States o Canada • Europe o Germany o France o United Kingdom o Rest of Europe • Asia Pacific o China o Japan o India o Rest of Asia Pacific • Latin America o Brazil o Rest of Latin America • Middle East & Africa o GCC o South Africa o Rest of MEA
List of Market Players 1. Baxter International (United States) 2. AbbVie Inc. (United States) 3. Hikma Pharmaceuticals (United Kingdom) 4. Lunan Pharmaceutical Group (China) 5. Piramal Enterprises (India) 6. Halocarbon Products Corporation (United States) 7. Medline Industries (United States) 8. Draegerwerk AG & Co. KGaA (Germany) 9. Koninklijke Philips N.V. (Netherlands) 10. Smiths Medical (United Kingdom) 11. GE Healthcare (United States) 12. Terumo Corporation (Japan) 13. B. Braun Melsungen AG (Germany) 14. Aspen Pharmacare Holdings Limited (South Africa) 15. Mindray Medical International Limited (China)
Drivers This inhalation anesthesia market is significantly driven by the increasing surgery prevalence around the world in chronic diseases like cancer and cardiovascular conditions as well as various neurological disorders. The continuously growing geriatric population of the world that is inclined to undergo surgeries is among one of the leading factors influencing growth in the global market, along with developments in drug delivery systems to improve security, efficiency, and rehabilitation time in patients. Rising healthcare expenditure and establishment of modern healthcare facilities in emerging economies further support the market. In addition, the development of minimally invasive surgeries requiring inhalation anesthesia has increased demand.
Restraints Market, despite its growth potential, faces several challenges in the form of high costs associated with inhalation anesthetic agents and their delivery systems. The regulatory approval process is quite stringent, and safety concerns over the environmental impact of anesthetic agents are major hurdles. Additionally, the risk of side effects such as nausea, vomiting, and possible long-term neurotoxicity in pediatric and geriatric patients affects market acceptance. The lack of access to sophisticated anesthetic infrastructure in low-income countries also limits the growth of the market. Competition from intravenous anesthesia techniques further adds to the market restraints.
Opportunities Huge opportunities exist for the development of an eco-friendly, less greenhouse-gas-emitting anesthetic agent. The increasing healthcare infrastructure in developing regions coupled with increasing adoption of sophisticated surgical techniques is also quite promising. The integration of AI and IoT in delivery systems, offering improved accuracy and safety, is quite promising in the near future. Increased establishment of ambulatory surgical centers along with personalized medicine is also contributing to driving opportunities in this market.
Trends Recent trends in the Global Inhalation Anesthesia Market have been toward low-flow anesthesia techniques to reduce waste and, therefore, costs. There is an increased adoption of green anesthesia practices to combat the environmental impact. Development in volatile anesthetic agents, with improved safety profiles, is in progress. Use of portable anesthetic delivery systems for outpatient surgeries and integration of AI in monitoring anesthesia during procedures is another transformative trend shaping the market landscape.
Key Target Audience • Hospitals and Healthcare Providers • Anesthesiologists • Ambulatory Surgical Centers • Pharmaceutical Companies • Research and Academic Institutions
Frequently Asked Questions (FAQ's)
The rising number of surgical procedures, advancements in anesthesia delivery systems, and increasing geriatric population are key growth drivers.
The market includes volatile anesthetics (sevoflurane, isoflurane, desflurane) and gaseous anesthetics (nitrous oxide).
North America and Europe dominate due to advanced healthcare infrastructure and high surgical volumes, while Asia Pacific is emerging as a growth hub.
High costs, regulatory barriers, and environmental concerns related to anesthetic agents are major challenges.
The development of eco-friendly anesthetic agents and adoption of green anesthesia practices address environmental issues.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Product Type 3.2.2 By Application 3.2.3 By End-User 3.2.4 By Distribution Channel 3.2.5 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Inhalation Anesthesia Market by Product Type 4.1 Introduction 4.2 Market Size and Growth Rate by Product Type (2024–2030) 4.2.1 Sevoflurane 4.2.2 Desflurane 4.2.3 Isoflurane 4.2.4 Others
5. Global Inhalation Anesthesia Market by Application 5.1 Introduction 5.2 Market Size and Growth Rate by Application (2024–2030) 5.2.1 Induction 5.2.2 Maintenance
6. Global Inhalation Anesthesia Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024–2030) 6.2.1 Hospitals 6.2.2 Ambulatory Surgical Centers 6.2.3 Clinics 6.2.4 Others
7. Global Inhalation Anesthesia Market by Distribution Channel 7.1 Introduction 7.2 Market Size and Growth Rate by Distribution Channel (2024–2030) 7.2.1 Direct Sales 7.2.2 Distributors 7.2.3 Online Sales
8. Global Inhalation Anesthesia Market by Geography 8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024–2030) 8.2.1 North America 8.2.1.1 United States 8.2.1.2 Canada 8.2.2 Europe 8.2.2.1 Germany 8.2.2.2 France 8.2.2.3 United Kingdom 8.2.2.4 Rest of Europe 8.2.3 Asia Pacific 8.2.3.1 China 8.2.3.2 Japan 8.2.3.3 India 8.2.3.4 Rest of Asia Pacific 8.2.4 Latin America 8.2.4.1 Brazil 8.2.4.2 Rest of Latin America 8.2.5 Middle East & Africa (MEA) 8.2.5.1 GCC 8.2.5.2 North Africa 8.2.5.3 South Africa 8.2.5.4 Rest of MEA
9. Competitive Landscape 9.1 Company Profiles 9.1.1 Baxter International Inc. (United States) 9.1.2 AbbVie Inc. (United States) 9.1.3 Hikma Pharmaceuticals PLC (United Kingdom) 9.1.4 Halocarbon Products Corporation (United States) 9.1.5 Piramal Enterprises Limited (India) 9.1.6 Fresenius Kabi AG (Germany) 9.1.7 Jiangsu Hengrui Medicine Co., Ltd. (China) 9.1.8 AstraZeneca PLC (United Kingdom) 9.1.9 Pfizer Inc. (United States) 9.1.10 Lunan Pharmaceutical Group Co. Ltd. (China)
10. List of Tables and Figures • Table 1: Global Inhalation Anesthesia Market Size (2024–2030) • Figure 1: Market Segmentation by Product Type • Table 2: Regional Distribution of Key Players • Figure 2: Market Dynamics and Growth Trends
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Inhalation Anesthesia Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Inhalation Anesthesia Market for the past year and forecasts for the next six years. Global Inhalation Anesthesia Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Inhalation Anesthesia Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Inhalation Anesthesia Market from different application industries in different regions.
Segmentation By Product Type • Volatile Anesthetics o Sevoflurane o Isoflurane o Desflurane o Others • Gaseous Anesthetics o Nitrous Oxide o Others
By Application • General Surgeries o Cardiovascular Surgeries o Neurosurgeries o Orthopedic Surgeries • Specialized Surgeries o Pediatric Surgeries o Obstetrics and Gynecology o Others
By End-User • Hospitals o Public Hospitals o Private Hospitals • Ambulatory Surgical Centers • Specialty Clinics
By Geography • North America o United States o Canada • Europe o Germany o France o United Kingdom o Rest of Europe • Asia Pacific o China o Japan o India o Rest of Asia Pacific • Latin America o Brazil o Rest of Latin America • Middle East & Africa o GCC o South Africa o Rest of MEA